Treatment with coumarin to prevent or delay recurrence of malignant melanoma

Journal of Cancer Research and Clinical Oncology

Volumn 120, Issue 1 Supplement, 1994, Pages

  Thornes, R D ^a   Daly, L ^a   Lynch, G ^a   Breslin, B ^a   Browne, H ^a   Browne, H Y ^a   Corrigan, T ^a   Daly, P ^a   Edwards, G ^a   Gaffney, E ^a   Henley, J ^a   Healy, T ^a   Keane, F ^a   Lennon, F ^a   McMurray, N ^a   O'Loughlin, S ^a   Shine, M ^a   Tanner, A ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Coumarin; Melanoma; Metastasis; Prevention; Recurrence

Indexed keywords

COUMARIN; PLACEBO;

CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MELANOMA; METASTASIS; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CHEMOTHERAPY, ADJUVANT; COUMARINS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIFE TABLES; MALE; MELANOMA; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES;

EID: 0028274246     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/BF01377122     Document Type: Article

References (11)

1. The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone)
2. The natural breakpoints for primary tumour thickness in clinical stage I melanoma
3. Treatment of renal cell carcinoma with coumarin: a review
4. The effect of coumarin and 7-hydroxycoumarin on the growth of human tumour cell lines
5. The ineffectiveness of coumarin treatment on thermal oedema of macrophage free rats
6. Synergistic effect of coumarin (1,2-benzopyrone) and endotoxin in the induction of human interleukin-1
7. Coumarins, melanoma and cellular immunity
8. Prevention of early recurrence of high risk malignant melanoma by coumarin
9. Effects of coumarins on interleukin 2 (IL-2) activity
10. Coumarin prevents tumorigenesis in MTV-H- ras transgenic mice